This process of recovER-phagy is highly characteristic for tumor cells expressing high amounts of SEC62 and therefore distinguishes tumor cells from surrounding cells and makes tumor cells potentially accessible for SEC62 targeted treatment (Bergmann et al., 2017). The gene discussed is SEC62; the disease is neoplasm.